Novartis may have a buyer for Sandoz; FDA suggests alternative approaches to assess nitrosamine risk
This week, Phispers brings you news on M&As, Covid
vaccines, lawsuits, regulations and more. Pfizer is expected to cross U...
Impressions : 2557
China to work with EU on aligning API standards; Lupin stumbles with FDA yet again
This week, Phispers has news from China, where its drug regulator said it would work with European Commission’s drug regu...
Impressions : 2239
Mylan’s valsartan facility gets FDA warning letter; US sues Gilead over HIV drug patents
This week, Phispers has news on Mylan’s valsartan facility in India receiving an FDA warning letter for nitrosamine conta...
Impressions : 4489
Insys founder Kapoor convicted in opioid scandal; FDA rules changing due to new technologies
This week, Phispers brings you news about John Kapoor, the founder of Insys who was found guilty of engaging in a bribery schem...
Impressions : 3742
Apotex explores sale; Perrigo looks at selling prescription business; Takeda puts Latam biz on the block
This week, Phispers has good news for patients on sartan drugs.
For the first time since nitrosamine impurities were discovere...
Impressions : 7468
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.